Drug Profile
Research programme: cancer therapeutics - Teva
Alternative Names: TV-4451Latest Information Update: 16 Aug 2011
Price :
$50
*
At a glance
- Originator Teva Pharmaceutical Industries
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 30 Sep 2006 Early research in Cancer in Israel (unspecified route)